116
Participants
Start Date
October 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
BAY 86-5310 (ZK 283197)
3 mg (3 x 1 mg tablet) or 2 mg (2 x 1 mg tablet) ZK 283197 in respective treatment group, once daily p.o. over 8 weeks
Placebo
Placebo, once daily p.o. over 8 weeks
17ß-estradiol
1 mg (2 x 0.5 mg tablet) 17ß-estradiol, once daily p.o. over 8 weeks
Berlin
Berlin
Groningen
Cambridge
Lead Sponsor
Bayer
INDUSTRY